Brief: Ryvu Therapeutics Q1 Net Loss At 25.3 Mln Zlotys
May 22 (Reuters) - Ryvu Therapeutics SA RVU.WA: Q1 NET LOSS AT 25.3 MILLION ZLOTYS Q1 SALES REVENUE AT 16.9 MILLION ZLOTYS Q1 OPERATING LOSS AT 37.7 MILLION ZLOTYS Source text: nEM1Kh3Mva Further company coverage: RVU.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys